Scarica l'app Stockscreener
102.92
0.14%
0.14
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$102.78
Aprire:
$102.92
Volume 24 ore:
1.53M
Relative Volume:
0.42
Capitalizzazione di mercato:
$18.75B
Reddito:
$381.03M
Utile/perdita netta:
$-1.01B
Rapporto P/E:
-17.30
EPS:
-5.95
Flusso di cassa netto:
$-789.25M
1 W Prestazione:
+0.05%
1M Prestazione:
+0.23%
6M Prestazione:
+31.19%
1 anno Prestazione:
+34.92%
Intervallo 1D:
$101.59
$103.74
Intervallo di 1 settimana:
$101.59
$105.35
Portata 52W:
$60.40
$106.83
Insmed Inc Stock (INSM) Company Profile
Nome
Insmed Inc
Settore
Industria
Telefono
908-977-9900
Indirizzo
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Confronta INSM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
102.92 | 19.54B | 381.03M | -1.01B | -789.25M | -5.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-13 | Iniziato | Jefferies | Buy |
| 2025-02-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-04-23 | Iniziato | Truist | Buy |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2023-11-20 | Ripresa | JP Morgan | Overweight |
| 2023-07-26 | Iniziato | Guggenheim | Buy |
| 2022-12-09 | Iniziato | Mizuho | Buy |
| 2022-12-07 | Iniziato | Barclays | Overweight |
| 2022-11-18 | Iniziato | BofA Securities | Buy |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2021-12-06 | Iniziato | JP Morgan | Overweight |
| 2021-10-19 | Ripresa | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-12-17 | Iniziato | Berenberg | Buy |
| 2020-10-12 | Ripresa | Stifel | Buy |
| 2019-09-03 | Iniziato | Goldman | Buy |
| 2019-04-09 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-15 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-01-02 | Iniziato | Canaccord Genuity | Buy |
| 2018-08-06 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Iniziato | Goldman | Neutral |
| 2018-04-23 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Iniziato | Morgan Stanley | Overweight |
| 2018-01-18 | Iniziato | Credit Suisse | Neutral |
| 2017-09-05 | Reiterato | Evercore ISI | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-11 | Iniziato | Robert W. Baird | Outperform |
| 2016-03-15 | Iniziato | Stifel | Buy |
| 2015-11-09 | Downgrade | UBS | Buy → Neutral |
| 2015-10-06 | Reiterato | H.C. Wainwright | Buy |
| 2015-06-09 | Iniziato | Citigroup | Neutral |
| 2014-03-26 | Reiterato | HC Wainwright | Buy |
Mostra tutto
Insmed Inc Borsa (INSM) Ultime notizie
What analysts say about Insmed Incorporated stockExceptional gains - jammulinksnews.com
What drives Insmed Incorporated stock priceFree Stock Market Real-Time Monitoring - jammulinksnews.com
Insmed Incorporated Stock Analysis and ForecastUnmatched profit growth - jammulinksnews.com
Is Insmed Incorporated a good long term investmentOver 200% growth - Autocar Professional
Insmed's Trading Volume Drops 46% to $208 Million Ranking 490th in Market - AInvest
Insmed (INSM) Target Price Raised by Morgan Stanley | INSM Stock News - GuruFocus
Insmed price target raised to $108 from $102 at Morgan Stanley - TipRanks
Insmed (INSM) Price Target Raised to $108 by Morgan Stanley | IN - GuruFocus
What makes Insmed Incorporated stock price move sharplyFree Capital Allocation Plans - beatles.ru
Insmed chief legal officer Smith sells $167,755 in stock By Investing.com - Investing.com Canada
Insmed chair and CEO Lewis sells $699k in shares By Investing.com - Investing.com Canada
Jim Cramer Calls Insmed "Very Speculative" - Yahoo Finance
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today - Benzinga
Insmed Surges to 292nd in Trading Volume with $31.9 Million Turnover - AInvest
Cramer Says Tesla Dominates While Ouster Is 'Too Speculative' - Benzinga
Insmed(INSM.US) Officer Sells US$5.54 Million in Common Stock - 富途牛牛
JPMorgan Elevates Insmed (INSM) Target Price Amid Positive Outlo - GuruFocus
A Glimpse Into The Expert Outlook On Insmed Through 12 Analysts - Nasdaq
RBC Capital Keeps Their Buy Rating on Insmed (INSM) - The Globe and Mail
United Therapeutics Faces Key Moment With Tyvaso's Q3 Results - Finimize
Insmed Incorporated(NasdaqGS: INSM) added to Russell Small Cap Comp Value Index - MarketScreener
Insmed Incorporated: Riding the Russell Reconstitution Wave in Small-Cap Biotech - AInvest
Insmed Surges to 134th in Trading Volume with $612 Million Day Despite Stock Decline - AInvest
Here’s how Insmed grows to be the next $100 billion biotech - statnews.com
Insmed's Insider Sell-Off: Strategic Exit or Buying Opportunity Ahead of Breakthrough Data? - AInvest
Pulmonary Arterial Hypertension Market Set to Grow Substantially Through 2034, DelveInsight Projects | Merck, Janssen Pharma, Aerovate Therapeutics, Novartis, Insmed Inc, Chugai Pharma, Keros - Barchart.com
Russell Rebalance: 3 Stocks Ready to Move Higher - MarketBeat
Insider Sell: Roger Adsett Sells 10,686 Shares of Insmed Inc (INSM) - GuruFocus
Mizuho Reiterates Outperform Rating on Insmed (INSM), Boosts PT to $110 - Insider Monkey
10 Best Growth Stocks to Buy According to Billionaires - Insider Monkey
Wells Fargo Lifts Price Target on Insmed Incorporated (INSM) to $119 From $107 - Insider Monkey
Insmed Trading Volume Plummets 51.8% to $217 Million Ranking 354th in Market Activity - AInvest
Is Insmed Stock Overvalued at $98? - Nasdaq
Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating - Insider Monkey
Insmed Completes $750 Million Follow-On Public Offering - Global Legal Chronicle
Is Insmed Stock Overvalued After The 45% Jump? - Forbes
Oracle, AST SpaceMobile And Halliburton Are Among Top 10 Large Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio? - Benzinga
Insmed Inc (INSM) Soars 30% on Impressive Study - MSN
Insmed Incorporated (INSM) Soars on Positive PAH Therapy Trial Results - Insider Monkey
INSM September 19th Options Begin Trading - Nasdaq
AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans - Yahoo Finance
Insmed (INSM) Soars After Raising $650 million - MSN
Insmed Stock Jumps 29% on Encouraging PAH Study Results - MSN
Finance Watch: Insmed Cashes In On Positive Data With $750m Offering - insights.citeline.com
Insmed Inc Azioni (INSM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):